Given the increased incidence of indolent prostate cancer since the advent of population-based PSA screening [37–39], this is very important to keep in mind when interpreting results of studies conducted in the last twenty years, as we have recently shown [40]. This evidence concerns the gene KLK3 and prostate carcinoma.